Portside

TPP's fate in congress is uncertain at best; Long-awaited text reveals gaps between administration claims and actual TPP terms on key congressional, public concerns. Many in Congress said they would support the TPP only if, at a minimum, it included past reforms made to trade pact intellectual property rules affecting access to affordable medicines. But the TPP rolls back that past progress and provides pharmaceutical firms with new monopoly rights for biotech drugs.

The US Department of Agriculture is hoping to expand a pilot program replacing half the USDA inspectors in meat plants with inspectors employed by the companies themselves, while speeding up production lines.

While the TPP is in many ways like NAFTA and other existing trade agreements, it appears that the corporations have learned from previous experience. They are carefully crafting the TPP to insure that citizens of the involved countries have no control over food safety, what they will be eating, where it is grown, the conditions under which food is grown and the use of herbicides and pesticides.